Flow-Through Electroporation Constriction for High Throughput Transformation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current electroporation methods for genetic engineering face challenges such as high cell mortality, low transformation efficiency, and limited scalability due to cell-type specificity and the need for precise optimization of electric field strength, particularly for bacterial cells where high electric fields can cause cell lysis or fail to introduce exogenous materials effectively.
Innovation Solution
The development of a flow-through electroporation system with a fluid transport structure featuring a constriction that amplifies the electric field, allowing for continuous delivery of cell suspensions through a microfluidic device with controlled voltage and pulse duration, optimizing electric field exposure for higher transfection efficiency and viability across various cell types, including bacteria and mammalian cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional electroporation methods are used to introduce genetic materials into cells, then transformation can be achieved, but cell mortality is high and transformation efficiency is low
Solution Approach 1:
The patent applies local quality by creating a non-uniform electric field distribution within the cuvette through strategically positioned electrodes. The electric field is concentrated in specific regions where cells are most densely located, ensuring that the electroporation effect is applied precisely where needed rather than uniformly throughout the entire sample volume. This localized approach increases transformation efficiency while reducing overall energy input and cell mortality.
Solution Approach 2:
The patent employs dynamic control of electroporation parameters including variable pulse duration, voltage amplitude, and waveform shape (exponential decay, square wave, damped sine wave). The system dynamically adjusts these parameters based on cell type and experimental conditions, allowing optimization of the electric field application to achieve maximum transformation efficiency while minimizing cell death. The pulsed nature of the electric field application represents a dynamic approach rather than continuous exposure.
2Reliability
If high electric field strength is applied to achieve effective transformation, then exogenous materials can be introduced into cells, but cell lysis occurs causing cell death
Solution Approach 1:
The patent uses periodic pulsed electric fields instead of continuous application. The electroporation pulses are delivered in controlled sequences with specific durations (microseconds to milliseconds) followed by recovery periods. This periodic action allows cells to undergo reversible electroporation during the pulse and recover during the inter-pulse interval, preventing irreversible lysis while still achieving effective genetic material introduction. The pulsed regime creates temporary pores that close before causing permanent damage.
Solution Approach 2:
The patent systematically varies multiple parameters including electric field strength, pulse duration, waveform shape, and number of pulses to optimize the balance between transformation efficiency and cell viability. By changing these parameters based on specific cell types and experimental requirements, the system can adjust the intensity and duration of electric field exposure to achieve effective electroporation without exceeding the threshold for cell lysis. This parameter optimization is critical for resolving the contradiction between sufficient field strength and cell survival.
3Reliability
If electroporation parameters are optimized for each cell type to achieve high transformation efficiency, then transformation can be effective, but the process becomes time-consuming and costly
Solution Approach 1:
The patent develops universal electroporation protocols and cuvette designs that can be applied across multiple cell types with minimal optimization required. The standardized cuvette geometry and electrode configurations create consistent electric field patterns that work effectively for various cell types including bacteria, yeast, and mammalian cells. This universality reduces the time and resources needed for optimization while maintaining high transformation efficiency across different applications.
Solution Approach 2:
The patent incorporates feedback mechanisms through systematic characterization of transformation efficiency across different parameter combinations and cell types. By establishing empirical relationships between electroporation parameters and transformation outcomes for various cell types, the system can predict optimal settings without extensive trial-and-error optimization. This feedback-based approach accelerates the optimization process by learning from previous experiments and applying that knowledge to new cell types or conditions.
4Productivity
If conventional cuvette-based electroporation is used, then transformation can be performed, but throughput is low limiting high-volume applications
Solution Approach 1:
The patent employs segmentation by dividing the cell suspension into multiple smaller aliquots that can be processed in parallel using multi-well plate formats or by performing multiple rapid sequential electroporations. This segmentation allows throughput to be increased by distributing the workload across multiple reaction vessels or time points, while each individual electroporation event maintains the transformation efficiency characteristics of the optimized protocol. The cuvette system is adapted to handle divided samples rather than attempting to process large volumes in a single electroporation event.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly enhances transfection efficiency and cell viability, enabling high-throughput transformation of cells with improved processing rates, up to 600 samples per hour, and increased transformation efficiency compared to traditional cuvette-based methods, while maintaining cell viability and reducing experimental costs.
Implementation Method 1
Electroporation uses pulsed electric fields to reversibly disrupt the cell envelope for intracellular delivery of exogenous materials, such as DNA
Implementation Method 2
The conductive elements are in operative arrangement with each other and are configured to expose cells contained within a cell suspension flowing through the fluid transport structure to an electric field that is sufficient to electroporate at least a subset of the cells in the flow path
Data Source
AI summary
Methods and apparatuses for cell electroporation are provided. An apparatus includes a fluid transport structure, such as a pipette, that includes an electroporation structure defining a flow path having a constriction. The fluid transport structure also includes at least two conductive elements configured to produce an electric field in the flow path. The conductive elements are in operative arrangement with each other and are configured to expose cells contained within a cell suspension flowing through the fluid transport structure to an electric field that is sufficient to electroporate at least a subset of the cells in the flow path.